ropivacaina kabi 2 mg/ml
fresenius kabi norge as - norvegia - ropivacainum - sol. inj. - 2mg/ml - anestezice locale amide
ropivacaina kabi 10 mg/ml
fresenius kabi norge as - norvegia - ropivacainum - sol. inj. - 10mg/ml - anestezice locale amide
ropivacaina bioq pharma readyfusor 10 mg/ora
geryon pharma ltd. - marea britanie - ropivacainum - sol. perf. in sist. de administrare - 10mg/ora - anestezice locale amide
ropivacaina villerton 2 mg/ml
infomed fluids s.r.l. - romania - ropivacainum - sol. perf. - 2 mg/ml - anestezice locale amide
ropivacaina villerton 2 mg/ml
infomed fluids s.r.l. - romania - ropivacainum - sol. perf. - 2 mg/ml - anestezice locale amide
ropivacaina infomed 2 mg/ml
infomed fluids s.r.l. - romania - ropivacainum - sol. perf. - 2mg/ml - anestezice locale amide
naropin 10 mg/ml
astrazeneca ab - suedia - ropivacainum - sol. inj. - 10mg/ml - anestezice locale amide
naropin 10 mg/ml
astrazeneca ab - suedia - ropivacainum - sol. inj. - 10mg/ml - anestezice locale amide
zynrelef
heron therapeutics, b.v. - bupivacaine, meloxicam - durere, postoperator - anestezice - zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.